Region: Australia

Landmark Dutch appeal court decision reduces risk of third-party damages against pharma patentees

The appellate ruling overturns a recent lower court judgment which exposed life sciences IP plaintiffs to significant additional dangers from health insurer lawsuits

06 January 2022

The biggest Asia-Pacific IP stories of 2021

Beyond China, there was a lot going on in a market that is home to some of the world’s most important patent-producing businesses

21 December 2021

Australia under-invests in IP, and recent government proposals will not fix that

Saturday Opinion: In-house leaders say a mooted patent box regime limited to life sciences will reward companies that get patents already, failing to encourage IP investment in new industries

04 December 2021

Courts split on AI inventorship and patenting

The Long Read: Those hoping for clarity on whether AI programmes can be regarded as inventors for patent purposes will be disappointed by the different ways in which courts around the world have handled the issue so far. Helen Macpherson, Tanvi Shah and Avi Toltzis of Baker & McKenzie look at recent developments

20 October 2021

How expedition is changing Australian pharma patent disputes

A growing trend in life sciences litigation Down Under has strategic implications for originators and generics/biosimilars alike

28 September 2021

The DABUS decision makes Australia look like a champion of innovation, not a chump

Saturday Opinion: Federal Court's AI inventorship decision should serve as a clarion call for Australia to lead on innovation issues

11 September 2021

Private practice leadership roundtable

Featured in Special Report 2021 Q3: IP leadership - what it is and why it matters

09 September 2021

Australian patent office appeals world-first decision allowing AI inventorship

IP Australia will continue its efforts to deny an application on the grounds that it lists DABUS, a computer program, as its inventor

30 August 2021

How the covid-19 pandemic has transformed the IP legal landscape

The Long Read: Top private practice partners based in Australia reflect on what it has taken to captain their firms through the events of the last 18 months and look at the ways in which the significant upheavals have affected the IP services industry

18 August 2021

Australian court decision to recognise non-humans as inventors is brave, verging on foolhardy

Ruling follows grant of patent to AI-generated invention in South Africa and raises a host of legal, policy and economic questions

02 August 2021

Get unlimited access to all IAM content